Lorediplon – 50 mg

Brand:
Cayman
CAS:
917393-39-6
Storage:
-20
UN-No:
Non-Hazardous - /

Lorediplon is a ligand for α1 subunit-containing GABAA receptors.{40790} In vivo, lorediplon inhibits spontaneous motor activity and increases duration of sleep in mice (ED50s = 0.13 and 1.2 mg/kg, respectively). It selectively inhibits spontaneous motor activity, which is driven by α1 subunit-containing GABAA receptors, over modification of muscular tone in mice, an α2 subunit-containing GABAA receptor-stimulated activity.{40791} Lorediplon (0.13 and 1.2 mg/kg) also decreases latency to slow wave sleep (SWS) and paradoxical sleep (PS) in mice.{40792} Formulations containing lorediplon have been used in the treatment of insomnia.  

 

Available on backorder

SKU: 23868 - 50 mg Category:

Description

A ligand for α1 subunit-containing GABAA receptors; inhibits spontaneous motor activity and increases duration of sleep in mice (ED50s = 0.13 and 1.2 mg/kg, respectively); selectively inhibits spontaneous motor activity, which is driven by α1 subunit-containing GABAA receptors, over modification of muscular tone in mice, an α2 subunit-containing GABAA receptor-stimulated activity; decreases latency to SWS and PS in mice (0.13 and 1.2 mg/kg)


Formal name: N-[2-fluoro-5-[3-(2-thienylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-N-methyl-acetamide

Synonyms: 

Molecular weight: 394.4

CAS: 917393-39-6

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Ion Channel Modulation|Activators||Research Area|Neuroscience|Behavioral Neuroscience|Sleep & Biological Rhythms